Font Size: a A A
Keyword [Valvular atrial fibrillation]
Result: 161 - 180 | Page: 9 of 10
161. Comparative Analysis Of The Safety And Efficacy Of Valve Replacement Plus Cox-maze ? Surgery Plus Left Atrial Volume Reduction At The Same Time
162. LDL-C/HDL-C Is Associated With Ischaemic Stroke In Patients With Valvular Atrial Fibrillation:A Case-control Study
163. Application Of Echocardiography In Percutaneous Left Atrial Appendage Closure In Patients With Non-valvular Atrial Fibrillation
164. Efficacy And Safety Of Left Atrial Appendage Closure And New Oral Anticoagulants In Stroke Prevention In Patients With Non-valvular Atrial Fibrillation:A Single Group Meta-analysis
165. Analysis Of The Status Quo And Influencing Factors Of Oral Anticoagulant Therapy In Patients With Non-valve Atrial Fibrillation In Class 3A Hospital
166. The Clinical Study Of Cardiac Structure And Function Changes And Risk Factors In Hypertensive Patients Complicating With Atrial Fibrillation
167. Application Of Transesophageal Echocardiography In Left Atrial Appendages Occlusion Combined With Catheter Ablation In Patients With Non-valvular Atrial Fibrillation
168. Safety And Efficacy Of 10mg Rivaroxaban For Non-Valvular Atrial Fibrillation:A Meta-Analysis
169. The Changes And Clinical Significance Of Gal-8,IL-18 And MCP-1 In Plasma Of Patients With Non-valvular Atrial Fibrillation
170. A Prospective Study Of The Diagnostic And Prognostic Value Of BNP And D-dimer In Patients With Cerebral Embolism In Non-valvular Atrial Fibrillation
171. Single-center Analysis Of The Current Status Of Anticoagulation Therapy And Influencing Factors In Patients With Non-valvular Atrial Fibrillation
172. Changes And Clinical Significance Of T Lymphocyte Subsets And Cytokines In Blood Of Patients With Non-valvular
173. Correlation Between Hyperuricemia And CHA2DS2-VASc Score In Patients With Nonvalvular Atrial Fibrillation
174. The Study Of Correlation Between Activated T Cell Nuclear Factor 4 And Interleukin 6 Levels And Non-valvular Atrial Fibrillation
175. Relationship Between Left Atrial Strain Measured By 4D Auto Left Atrial Quantitative Analysis And Embolism Risk In Patients With Non-valvular Atrial Fibrillation
176. Risk Factors Analysis Of Patients With Non-valvular Atrial Fibrillation In Qinghai Area
177. Incidence Of Left Atrial/left Atrial Appendage Thrombosis In Patients With Non Valvular Atrial Fibrillation And Its Anticoagulant Therapy Evaluation Of Efficacy And Safety:A Meta-analysis
178. Relationship Between Total Bilirubin And Left Atrial Appendage Thrombus In Patients With Non-valvular Atrial Fibrillation
179. Predictive Effect Of Monocyte To High-density Lipoprotein Ratio On Stroke In Patients With Nonvalvular Atrial Fibrillation
180. Population Pharmacokinetics And Pharmacodynamics Of Rivaroxaban In Patients With Non-valvular Atrial Fibrillation
  <<First  <Prev  Next>  Last>>  Jump to